Global Biomaterials Market Insights, Forecast to 2029

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Biomaterials Product Introduction
• 1.2 Market by Materials
  • 1.2.1 Global Biomaterials Market Size by Materials, 2018 VS 2022 VS 2029
  • 1.2.2 Metallic Biomaterial
  • 1.2.3 Ceramic Biomaterial
  • 1.2.4 Polymeric Biomaterial
  • 1.2.5 Natural Biomaterial
  • 1.2.6 Composites
• 1.3 Market by Application
  • 1.3.1 Global Biomaterials Market Size by Application, 2018 VS 2022 VS 2029
  • 1.3.2 Medical Application
  • 1.3.3 Laboratories
  • 1.3.4 Industrial Application
  • 1.3.5 Research Institutions
  • 1.3.6 Other
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Biomaterials Production

• 2.1 Global Biomaterials Production Capacity (2018-2029)
• 2.2 Global Biomaterials Production by Region: 2018 VS 2022 VS 2029
• 2.3 Global Biomaterials Production by Region
  • 2.3.1 Global Biomaterials Historic Production by Region (2018-2023)
  • 2.3.2 Global Biomaterials Forecasted Production by Region (2024-2029)
  • 2.3.3 Global Biomaterials Production Market Share by Region (2018-2029)
• 2.4 North America
• 2.5 Europe
• 2.6 China
• 2.7 Japan

3 Executive Summary

• 3.1 Global Biomaterials Revenue Estimates and Forecasts 2018-2029
• 3.2 Global Biomaterials Revenue by Region
  • 3.2.1 Global Biomaterials Revenue by Region: 2018 VS 2022 VS 2029
  • 3.2.2 Global Biomaterials Revenue by Region (2018-2023)
  • 3.2.3 Global Biomaterials Revenue by Region (2024-2029)
  • 3.2.4 Global Biomaterials Revenue Market Share by Region (2018-2029)
• 3.3 Global Biomaterials Sales Estimates and Forecasts 2018-2029
• 3.4 Global Biomaterials Sales by Region
  • 3.4.1 Global Biomaterials Sales by Region: 2018 VS 2022 VS 2029
  • 3.4.2 Global Biomaterials Sales by Region (2018-2023)
  • 3.4.3 Global Biomaterials Sales by Region (2024-2029)
  • 3.4.4 Global Biomaterials Sales Market Share by Region (2018-2029)
• 3.5 US & Canada
• 3.6 Europe
• 3.7 China
• 3.8 Asia (excluding China)
• 3.9 Middle East, Africa and Latin America

4 Competition by Manufactures

• 4.1 Global Biomaterials Sales by Manufacturers
  • 4.1.1 Global Biomaterials Sales by Manufacturers (2018-2023)
  • 4.1.2 Global Biomaterials Sales Market Share by Manufacturers (2018-2023)
  • 4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Biomaterials in 2022
• 4.2 Global Biomaterials Revenue by Manufacturers
  • 4.2.1 Global Biomaterials Revenue by Manufacturers (2018-2023)
  • 4.2.2 Global Biomaterials Revenue Market Share by Manufacturers (2018-2023)
  • 4.2.3 Global Top 10 and Top 5 Companies by Biomaterials Revenue in 2022
• 4.3 Global Biomaterials Sales Price by Manufacturers
• 4.4 Global Key Players of Biomaterials, Industry Ranking, 2021 VS 2022 VS 2023
• 4.5 Analysis of Competitive Landscape
  • 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 4.5.2 Global Biomaterials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 4.6 Global Key Manufacturers of Biomaterials, Manufacturing Base Distribution and Headquarters
• 4.7 Global Key Manufacturers of Biomaterials, Product Offered and Application
• 4.8 Global Key Manufacturers of Biomaterials, Date of Enter into This Industry
• 4.9 Mergers & Acquisitions, Expansion Plans

5 Market Size by Materials

• 5.1 Global Biomaterials Sales by Materials
  • 5.1.1 Global Biomaterials Historical Sales by Materials (2018-2023)
  • 5.1.2 Global Biomaterials Forecasted Sales by Materials (2024-2029)
  • 5.1.3 Global Biomaterials Sales Market Share by Materials (2018-2029)
• 5.2 Global Biomaterials Revenue by Materials
  • 5.2.1 Global Biomaterials Historical Revenue by Materials (2018-2023)
  • 5.2.2 Global Biomaterials Forecasted Revenue by Materials (2024-2029)
  • 5.2.3 Global Biomaterials Revenue Market Share by Materials (2018-2029)
• 5.3 Global Biomaterials Price by Materials
  • 5.3.1 Global Biomaterials Price by Materials (2018-2023)
  • 5.3.2 Global Biomaterials Price Forecast by Materials (2024-2029)

6 Market Size by Application

• 6.1 Global Biomaterials Sales by Application
  • 6.1.1 Global Biomaterials Historical Sales by Application (2018-2023)
  • 6.1.2 Global Biomaterials Forecasted Sales by Application (2024-2029)
  • 6.1.3 Global Biomaterials Sales Market Share by Application (2018-2029)
• 6.2 Global Biomaterials Revenue by Application
  • 6.2.1 Global Biomaterials Historical Revenue by Application (2018-2023)
  • 6.2.2 Global Biomaterials Forecasted Revenue by Application (2024-2029)
  • 6.2.3 Global Biomaterials Revenue Market Share by Application (2018-2029)
• 6.3 Global Biomaterials Price by Application
  • 6.3.1 Global Biomaterials Price by Application (2018-2023)
  • 6.3.2 Global Biomaterials Price Forecast by Application (2024-2029)

7 US & Canada

• 7.1 US & Canada Biomaterials Market Size by Materials
  • 7.1.1 US & Canada Biomaterials Sales by Materials (2018-2029)
  • 7.1.2 US & Canada Biomaterials Revenue by Materials (2018-2029)
• 7.2 US & Canada Biomaterials Market Size by Application
  • 7.2.1 US & Canada Biomaterials Sales by Application (2018-2029)
  • 7.2.2 US & Canada Biomaterials Revenue by Application (2018-2029)
• 7.3 US & Canada Biomaterials Sales by Country
  • 7.3.1 US & Canada Biomaterials Revenue by Country: 2018 VS 2022 VS 2029
  • 7.3.2 US & Canada Biomaterials Sales by Country (2018-2029)
  • 7.3.3 US & Canada Biomaterials Revenue by Country (2018-2029)
  • 7.3.4 U.S.
  • 7.3.5 Canada

8 Europe

• 8.1 Europe Biomaterials Market Size by Materials
  • 8.1.1 Europe Biomaterials Sales by Materials (2018-2029)
  • 8.1.2 Europe Biomaterials Revenue by Materials (2018-2029)
• 8.2 Europe Biomaterials Market Size by Application
  • 8.2.1 Europe Biomaterials Sales by Application (2018-2029)
  • 8.2.2 Europe Biomaterials Revenue by Application (2018-2029)
• 8.3 Europe Biomaterials Sales by Country
  • 8.3.1 Europe Biomaterials Revenue by Country: 2018 VS 2022 VS 2029
  • 8.3.2 Europe Biomaterials Sales by Country (2018-2029)
  • 8.3.3 Europe Biomaterials Revenue by Country (2018-2029)
  • 8.3.4 Germany
  • 8.3.5 France
  • 8.3.6 U.K.
  • 8.3.7 Italy
  • 8.3.8 Russia

9 China

• 9.1 China Biomaterials Market Size by Materials
  • 9.1.1 China Biomaterials Sales by Materials (2018-2029)
  • 9.1.2 China Biomaterials Revenue by Materials (2018-2029)
• 9.2 China Biomaterials Market Size by Application
  • 9.2.1 China Biomaterials Sales by Application (2018-2029)
  • 9.2.2 China Biomaterials Revenue by Application (2018-2029)

10 Asia (excluding China)

• 10.1 Asia Biomaterials Market Size by Materials
  • 10.1.1 Asia Biomaterials Sales by Materials (2018-2029)
  • 10.1.2 Asia Biomaterials Revenue by Materials (2018-2029)
• 10.2 Asia Biomaterials Market Size by Application
  • 10.2.1 Asia Biomaterials Sales by Application (2018-2029)
  • 10.2.2 Asia Biomaterials Revenue by Application (2018-2029)
• 10.3 Asia Biomaterials Sales by Region
  • 10.3.1 Asia Biomaterials Revenue by Region: 2018 VS 2022 VS 2029
  • 10.3.2 Asia Biomaterials Revenue by Region (2018-2029)
  • 10.3.3 Asia Biomaterials Sales by Region (2018-2029)
  • 10.3.4 Japan
  • 10.3.5 South Korea
  • 10.3.6 China Taiwan
  • 10.3.7 Southeast Asia
  • 10.3.8 India

11 Middle East, Africa and Latin America

• 11.1 Middle East, Africa and Latin America Biomaterials Market Size by Materials
  • 11.1.1 Middle East, Africa and Latin America Biomaterials Sales by Materials (2018-2029)
  • 11.1.2 Middle East, Africa and Latin America Biomaterials Revenue by Materials (2018-2029)
• 11.2 Middle East, Africa and Latin America Biomaterials Market Size by Application
  • 11.2.1 Middle East, Africa and Latin America Biomaterials Sales by Application (2018-2029)
  • 11.2.2 Middle East, Africa and Latin America Biomaterials Revenue by Application (2018-2029)
• 11.3 Middle East, Africa and Latin America Biomaterials Sales by Country
  • 11.3.1 Middle East, Africa and Latin America Biomaterials Revenue by Country: 2018 VS 2022 VS 2029
  • 11.3.2 Middle East, Africa and Latin America Biomaterials Revenue by Country (2018-2029)
  • 11.3.3 Middle East, Africa and Latin America Biomaterials Sales by Country (2018-2029)
  • 11.3.4 Brazil
  • 11.3.5 Mexico
  • 11.3.6 Turkey
  • 11.3.7 Israel
  • 11.3.8 GCC Countries

12 Corporate Profiles

• 12.1 Abbott
  • 12.1.1 Abbott Company Information
  • 12.1.2 Abbott Overview
  • 12.1.3 Abbott Biomaterials Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.1.4 Abbott Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.1.5 Abbott Recent Developments
• 12.2 Actavis
  • 12.2.1 Actavis Company Information
  • 12.2.2 Actavis Overview
  • 12.2.3 Actavis Biomaterials Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.2.4 Actavis Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.2.5 Actavis Recent Developments
• 12.3 Anika Therapeutics
  • 12.3.1 Anika Therapeutics Company Information
  • 12.3.2 Anika Therapeutics Overview
  • 12.3.3 Anika Therapeutics Biomaterials Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.3.4 Anika Therapeutics Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.3.5 Anika Therapeutics Recent Developments
• 12.4 Arthrex
  • 12.4.1 Arthrex Company Information
  • 12.4.2 Arthrex Overview
  • 12.4.3 Arthrex Biomaterials Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.4.4 Arthrex Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.4.5 Arthrex Recent Developments
• 12.5 Berkeley Advanced Biomaterials(BAB)
  • 12.5.1 Berkeley Advanced Biomaterials(BAB) Company Information
  • 12.5.2 Berkeley Advanced Biomaterials(BAB) Overview
  • 12.5.3 Berkeley Advanced Biomaterials(BAB) Biomaterials Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.5.4 Berkeley Advanced Biomaterials(BAB) Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.5.5 Berkeley Advanced Biomaterials(BAB) Recent Developments
• 12.6 Zimmer Biomet
  • 12.6.1 Zimmer Biomet Company Information
  • 12.6.2 Zimmer Biomet Overview
  • 12.6.3 Zimmer Biomet Biomaterials Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.6.4 Zimmer Biomet Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.6.5 Zimmer Biomet Recent Developments
• 12.7 Johnson & Johnson
  • 12.7.1 Johnson & Johnson Company Information
  • 12.7.2 Johnson & Johnson Overview
  • 12.7.3 Johnson & Johnson Biomaterials Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.7.4 Johnson & Johnson Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.7.5 Johnson & Johnson Recent Developments
• 12.8 Invibio
  • 12.8.1 Invibio Company Information
  • 12.8.2 Invibio Overview
  • 12.8.3 Invibio Biomaterials Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.8.4 Invibio Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.8.5 Invibio Recent Developments
• 12.9 Medtronic
  • 12.9.1 Medtronic Company Information
  • 12.9.2 Medtronic Overview
  • 12.9.3 Medtronic Biomaterials Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.9.4 Medtronic Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.9.5 Medtronic Recent Developments
• 12.10 Organogenesis
  • 12.10.1 Organogenesis Company Information
  • 12.10.2 Organogenesis Overview
  • 12.10.3 Organogenesis Biomaterials Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.10.4 Organogenesis Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.10.5 Organogenesis Recent Developments
• 12.11 Stryker
  • 12.11.1 Stryker Company Information
  • 12.11.2 Stryker Overview
  • 12.11.3 Stryker Biomaterials Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.11.4 Stryker Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.11.5 Stryker Recent Developments
• 12.12 Wright Medical Group N.V.
  • 12.12.1 Wright Medical Group N.V. Company Information
  • 12.12.2 Wright Medical Group N.V. Overview
  • 12.12.3 Wright Medical Group N.V. Biomaterials Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.12.4 Wright Medical Group N.V. Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.12.5 Wright Medical Group N.V. Recent Developments
• 12.13 3M Healthcare
  • 12.13.1 3M Healthcare Company Information
  • 12.13.2 3M Healthcare Overview
  • 12.13.3 3M Healthcare Biomaterials Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.13.4 3M Healthcare Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.13.5 3M Healthcare Recent Developments
• 12.14 Advansource Biomaterials Corporation
  • 12.14.1 Advansource Biomaterials Corporation Company Information
  • 12.14.2 Advansource Biomaterials Corporation Overview
  • 12.14.3 Advansource Biomaterials Corporation Biomaterials Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.14.4 Advansource Biomaterials Corporation Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.14.5 Advansource Biomaterials Corporation Recent Developments
• 12.15 Baxter
  • 12.15.1 Baxter Company Information
  • 12.15.2 Baxter Overview
  • 12.15.3 Baxter Biomaterials Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.15.4 Baxter Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.15.5 Baxter Recent Developments
• 12.16 Covestro
  • 12.16.1 Covestro Company Information
  • 12.16.2 Covestro Overview
  • 12.16.3 Covestro Biomaterials Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.16.4 Covestro Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.16.5 Covestro Recent Developments
• 12.17 Solvay Advanced Polymers
  • 12.17.1 Solvay Advanced Polymers Company Information
  • 12.17.2 Solvay Advanced Polymers Overview
  • 12.17.3 Solvay Advanced Polymers Biomaterials Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.17.4 Solvay Advanced Polymers Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.17.5 Solvay Advanced Polymers Recent Developments

13 Industry Chain and Sales Channels Analysis

• 13.1 Biomaterials Industry Chain Analysis
• 13.2 Biomaterials Key Raw Materials
  • 13.2.1 Key Raw Materials
  • 13.2.2 Raw Materials Key Suppliers
• 13.3 Biomaterials Production Mode & Process
• 13.4 Biomaterials Sales and Marketing
  • 13.4.1 Biomaterials Sales Channels
  • 13.4.2 Biomaterials Distributors
• 13.5 Biomaterials Customers

14 Biomaterials Market Dynamics

• 14.1 Biomaterials Industry Trends
• 14.2 Biomaterials Market Drivers
• 14.3 Biomaterials Market Challenges
• 14.4 Biomaterials Market Restraints

15 Key Finding in The Global Biomaterials Study

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details
• 16.3 Disclaimer

List of Tables

• Table 1. Global Biomaterials Market Size Growth Rate by Materials, 2018 VS 2022 VS 2029 (US$ Million)
• Table 2. Major Manufacturers of Metallic Biomaterial
• Table 3. Major Manufacturers of Ceramic Biomaterial
• Table 4. Major Manufacturers of Polymeric Biomaterial
• Table 5. Major Manufacturers of Natural Biomaterial
• Table 6. Major Manufacturers of Composites
• Table 7. Global Biomaterials Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
• Table 8. Global Biomaterials Production by Region: 2018 VS 2022 VS 2029 (MT)
• Table 9. Global Biomaterials Production by Region (2018-2023) & (MT)
• Table 10. Global Biomaterials Production by Region (2024-2029) & (MT)
• Table 11. Global Biomaterials Production Market Share by Region (2018-2023)
• Table 12. Global Biomaterials Production Market Share by Region (2024-2029)
• Table 13. Global Biomaterials Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
• Table 14. Global Biomaterials Revenue by Region (2018-2023) & (US$ Million)
• Table 15. Global Biomaterials Revenue by Region (2024-2029) & (US$ Million)
• Table 16. Global Biomaterials Revenue Market Share by Region (2018-2023)
• Table 17. Global Biomaterials Revenue Market Share by Region (2024-2029)
• Table 18. Global Biomaterials Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
• Table 19. Global Biomaterials Sales by Region (2018-2023) & (MT)
• Table 20. Global Biomaterials Sales by Region (2024-2029) & (MT)
• Table 21. Global Biomaterials Sales Market Share by Region (2018-2023)
• Table 22. Global Biomaterials Sales Market Share by Region (2024-2029)
• Table 23. Global Biomaterials Sales by Manufacturers (2018-2023) & (MT)
• Table 24. Global Biomaterials Sales Share by Manufacturers (2018-2023)
• Table 25. Global Biomaterials Revenue by Manufacturers (2018-2023) & (US$ Million)
• Table 26. Global Biomaterials Revenue Share by Manufacturers (2018-2023)
• Table 27. Biomaterials Price by Manufacturers 2018-2023 (USD/MT)
• Table 28. Global Key Players of Biomaterials, Industry Ranking, 2021 VS 2022 VS 2023
• Table 29. Global Biomaterials Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 30. Global Biomaterials by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomaterials as of 2022)
• Table 31. Global Key Manufacturers of Biomaterials, Manufacturing Base Distribution and Headquarters
• Table 32. Global Key Manufacturers of Biomaterials, Product Offered and Application
• Table 33. Global Key Manufacturers of Biomaterials, Date of Enter into This Industry
• Table 34. Mergers & Acquisitions, Expansion Plans
• Table 35. Global Biomaterials Sales by Materials (2018-2023) & (MT)
• Table 36. Global Biomaterials Sales by Materials (2024-2029) & (MT)
• Table 37. Global Biomaterials Sales Share by Materials (2018-2023)
• Table 38. Global Biomaterials Sales Share by Materials (2024-2029)
• Table 39. Global Biomaterials Revenue by Materials (2018-2023) & (US$ Million)
• Table 40. Global Biomaterials Revenue by Materials (2024-2029) & (US$ Million)
• Table 41. Global Biomaterials Revenue Share by Materials (2018-2023)
• Table 42. Global Biomaterials Revenue Share by Materials (2024-2029)
• Table 43. Biomaterials Price by Materials (2018-2023) & (USD/MT)
• Table 44. Global Biomaterials Price Forecast by Materials (2024-2029) & (USD/MT)
• Table 45. Global Biomaterials Sales by Application (2018-2023) & (MT)
• Table 46. Global Biomaterials Sales by Application (2024-2029) & (MT)
• Table 47. Global Biomaterials Sales Share by Application (2018-2023)
• Table 48. Global Biomaterials Sales Share by Application (2024-2029)
• Table 49. Global Biomaterials Revenue by Application (2018-2023) & (US$ Million)
• Table 50. Global Biomaterials Revenue by Application (2024-2029) & (US$ Million)
• Table 51. Global Biomaterials Revenue Share by Application (2018-2023)
• Table 52. Global Biomaterials Revenue Share by Application (2024-2029)
• Table 53. Biomaterials Price by Application (2018-2023) & (USD/MT)
• Table 54. Global Biomaterials Price Forecast by Application (2024-2029) & (USD/MT)
• Table 55. US & Canada Biomaterials Sales by Materials (2018-2023) & (MT)
• Table 56. US & Canada Biomaterials Sales by Materials (2024-2029) & (MT)
• Table 57. US & Canada Biomaterials Revenue by Materials (2018-2023) & (US$ Million)
• Table 58. US & Canada Biomaterials Revenue by Materials (2024-2029) & (US$ Million)
• Table 59. US & Canada Biomaterials Sales by Application (2018-2023) & (MT)
• Table 60. US & Canada Biomaterials Sales by Application (2024-2029) & (MT)
• Table 61. US & Canada Biomaterials Revenue by Application (2018-2023) & (US$ Million)
• Table 62. US & Canada Biomaterials Revenue by Application (2024-2029) & (US$ Million)
• Table 63. US & Canada Biomaterials Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 64. US & Canada Biomaterials Revenue by Country (2018-2023) & (US$ Million)
• Table 65. US & Canada Biomaterials Revenue by Country (2024-2029) & (US$ Million)
• Table 66. US & Canada Biomaterials Sales by Country (2018-2023) & (MT)
• Table 67. US & Canada Biomaterials Sales by Country (2024-2029) & (MT)
• Table 68. Europe Biomaterials Sales by Materials (2018-2023) & (MT)
• Table 69. Europe Biomaterials Sales by Materials (2024-2029) & (MT)
• Table 70. Europe Biomaterials Revenue by Materials (2018-2023) & (US$ Million)
• Table 71. Europe Biomaterials Revenue by Materials (2024-2029) & (US$ Million)
• Table 72. Europe Biomaterials Sales by Application (2018-2023) & (MT)
• Table 73. Europe Biomaterials Sales by Application (2024-2029) & (MT)
• Table 74. Europe Biomaterials Revenue by Application (2018-2023) & (US$ Million)
• Table 75. Europe Biomaterials Revenue by Application (2024-2029) & (US$ Million)
• Table 76. Europe Biomaterials Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 77. Europe Biomaterials Revenue by Country (2018-2023) & (US$ Million)
• Table 78. Europe Biomaterials Revenue by Country (2024-2029) & (US$ Million)
• Table 79. Europe Biomaterials Sales by Country (2018-2023) & (MT)
• Table 80. Europe Biomaterials Sales by Country (2024-2029) & (MT)
• Table 81. China Biomaterials Sales by Materials (2018-2023) & (MT)
• Table 82. China Biomaterials Sales by Materials (2024-2029) & (MT)
• Table 83. China Biomaterials Revenue by Materials (2018-2023) & (US$ Million)
• Table 84. China Biomaterials Revenue by Materials (2024-2029) & (US$ Million)
• Table 85. China Biomaterials Sales by Application (2018-2023) & (MT)
• Table 86. China Biomaterials Sales by Application (2024-2029) & (MT)
• Table 87. China Biomaterials Revenue by Application (2018-2023) & (US$ Million)
• Table 88. China Biomaterials Revenue by Application (2024-2029) & (US$ Million)
• Table 89. Asia Biomaterials Sales by Materials (2018-2023) & (MT)
• Table 90. Asia Biomaterials Sales by Materials (2024-2029) & (MT)
• Table 91. Asia Biomaterials Revenue by Materials (2018-2023) & (US$ Million)
• Table 92. Asia Biomaterials Revenue by Materials (2024-2029) & (US$ Million)
• Table 93. Asia Biomaterials Sales by Application (2018-2023) & (MT)
• Table 94. Asia Biomaterials Sales by Application (2024-2029) & (MT)
• Table 95. Asia Biomaterials Revenue by Application (2018-2023) & (US$ Million)
• Table 96. Asia Biomaterials Revenue by Application (2024-2029) & (US$ Million)
• Table 97. Asia Biomaterials Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 98. Asia Biomaterials Revenue by Region (2018-2023) & (US$ Million)
• Table 99. Asia Biomaterials Revenue by Region (2024-2029) & (US$ Million)
• Table 100. Asia Biomaterials Sales by Region (2018-2023) & (MT)
• Table 101. Asia Biomaterials Sales by Region (2024-2029) & (MT)
• Table 102. Middle East, Africa and Latin America Biomaterials Sales by Materials (2018-2023) & (MT)
• Table 103. Middle East, Africa and Latin America Biomaterials Sales by Materials (2024-2029) & (MT)
• Table 104. Middle East, Africa and Latin America Biomaterials Revenue by Materials (2018-2023) & (US$ Million)
• Table 105. Middle East, Africa and Latin America Biomaterials Revenue by Materials (2024-2029) & (US$ Million)
• Table 106. Middle East, Africa and Latin America Biomaterials Sales by Application (2018-2023) & (MT)
• Table 107. Middle East, Africa and Latin America Biomaterials Sales by Application (2024-2029) & (MT)
• Table 108. Middle East, Africa and Latin America Biomaterials Revenue by Application (2018-2023) & (US$ Million)
• Table 109. Middle East, Africa and Latin America Biomaterials Revenue by Application (2024-2029) & (US$ Million)
• Table 110. Middle East, Africa and Latin America Biomaterials Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 111. Middle East, Africa and Latin America Biomaterials Revenue by Country (2018-2023) & (US$ Million)
• Table 112. Middle East, Africa and Latin America Biomaterials Revenue by Country (2024-2029) & (US$ Million)
• Table 113. Middle East, Africa and Latin America Biomaterials Sales by Country (2018-2023) & (MT)
• Table 114. Middle East, Africa and Latin America Biomaterials Sales by Country (2024-2029) & (MT)
• Table 115. Abbott Company Information
• Table 116. Abbott Description and Major Businesses
• Table 117. Abbott Biomaterials Capacity Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
• Table 118. Abbott Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
• Table 119. Abbott Recent Development
• Table 120. Actavis Company Information
• Table 121. Actavis Description and Major Businesses
• Table 122. Actavis Biomaterials Capacity Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
• Table 123. Actavis Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
• Table 124. Actavis Recent Development
• Table 125. Anika Therapeutics Company Information
• Table 126. Anika Therapeutics Description and Major Businesses
• Table 127. Anika Therapeutics Biomaterials Capacity Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
• Table 128. Anika Therapeutics Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
• Table 129. Anika Therapeutics Recent Development
• Table 130. Arthrex Company Information
• Table 131. Arthrex Description and Major Businesses
• Table 132. Arthrex Biomaterials Capacity Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
• Table 133. Arthrex Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
• Table 134. Arthrex Recent Development
• Table 135. Berkeley Advanced Biomaterials(BAB) Company Information
• Table 136. Berkeley Advanced Biomaterials(BAB) Description and Major Businesses
• Table 137. Berkeley Advanced Biomaterials(BAB) Biomaterials Capacity Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
• Table 138. Berkeley Advanced Biomaterials(BAB) Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
• Table 139. Berkeley Advanced Biomaterials(BAB) Recent Development
• Table 140. Zimmer Biomet Company Information
• Table 141. Zimmer Biomet Description and Major Businesses
• Table 142. Zimmer Biomet Biomaterials Capacity Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
• Table 143. Zimmer Biomet Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
• Table 144. Zimmer Biomet Recent Development
• Table 145. Johnson & Johnson Company Information
• Table 146. Johnson & Johnson Description and Major Businesses
• Table 147. Johnson & Johnson Biomaterials Capacity Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
• Table 148. Johnson & Johnson Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
• Table 149. Johnson & Johnson Recent Development
• Table 150. Invibio Company Information
• Table 151. Invibio Description and Major Businesses
• Table 152. Invibio Biomaterials Capacity Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
• Table 153. Invibio Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
• Table 154. Invibio Recent Development
• Table 155. Medtronic Company Information
• Table 156. Medtronic Description and Major Businesses
• Table 157. Medtronic Biomaterials Capacity Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
• Table 158. Medtronic Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
• Table 159. Medtronic Recent Development
• Table 160. Organogenesis Company Information
• Table 161. Organogenesis Description and Major Businesses
• Table 162. Organogenesis Biomaterials Capacity Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
• Table 163. Organogenesis Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
• Table 164. Organogenesis Recent Development
• Table 165. Stryker Company Information
• Table 166. Stryker Description and Major Businesses
• Table 167. Stryker Biomaterials Capacity Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
• Table 168. Stryker Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
• Table 169. Stryker Recent Development
• Table 170. Wright Medical Group N.V. Company Information
• Table 171. Wright Medical Group N.V. Description and Major Businesses
• Table 172. Wright Medical Group N.V. Biomaterials Capacity Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
• Table 173. Wright Medical Group N.V. Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
• Table 174. Wright Medical Group N.V. Recent Development
• Table 175. 3M Healthcare Company Information
• Table 176. 3M Healthcare Description and Major Businesses
• Table 177. 3M Healthcare Biomaterials Capacity Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
• Table 178. 3M Healthcare Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
• Table 179. 3M Healthcare Recent Development
• Table 180. Advansource Biomaterials Corporation Company Information
• Table 181. Advansource Biomaterials Corporation Description and Major Businesses
• Table 182. Advansource Biomaterials Corporation Biomaterials Capacity Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
• Table 183. Advansource Biomaterials Corporation Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
• Table 184. Advansource Biomaterials Corporation Recent Development
• Table 185. Baxter Company Information
• Table 186. Baxter Description and Major Businesses
• Table 187. Baxter Biomaterials Capacity Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
• Table 188. Baxter Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
• Table 189. Baxter Recent Development
• Table 190. Covestro Company Information
• Table 191. Covestro Description and Major Businesses
• Table 192. Covestro Biomaterials Capacity Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
• Table 193. Covestro Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
• Table 194. Covestro Recent Development
• Table 195. Solvay Advanced Polymers Company Information
• Table 196. Solvay Advanced Polymers Description and Major Businesses
• Table 197. Solvay Advanced Polymers Biomaterials Capacity Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
• Table 198. Solvay Advanced Polymers Biomaterials Product Model Numbers, Pictures, Descriptions and Specifications
• Table 199. Solvay Advanced Polymers Recent Development
• Table 200. Key Raw Materials Lists
• Table 201. Raw Materials Key Suppliers Lists
• Table 202. Biomaterials Distributors List
• Table 203. Biomaterials Customers List
• Table 204. Biomaterials Market Trends
• Table 205. Biomaterials Market Drivers
• Table 206. Biomaterials Market Challenges
• Table 207. Biomaterials Market Restraints
• Table 208. Research Programs/Design for This Report
• Table 209. Key Data Information from Secondary Sources
• Table 210. Key Data Information from Primary Sources

List of Figures

• Figure 1. Biomaterials Product Picture
• Figure 2. Global Biomaterials Market Size Growth Rate by Materials, 2018 VS 2022 VS 2029 (US$ Million)
• Figure 3. Global Biomaterials Market Share by Materials in 2022 & 2029
• Figure 4. Metallic Biomaterial Product Picture
• Figure 5. Ceramic Biomaterial Product Picture
• Figure 6. Polymeric Biomaterial Product Picture
• Figure 7. Natural Biomaterial Product Picture
• Figure 8. Composites Product Picture
• Figure 9. Global Biomaterials Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
• Figure 10. Global Biomaterials Market Share by Application in 2022 & 2029
• Figure 11. Medical Application
• Figure 12. Laboratories
• Figure 13. Industrial Application
• Figure 14. Research Institutions
• Figure 15. Other
• Figure 16. Biomaterials Report Years Considered
• Figure 17. Global Biomaterials Capacity, Production and Utilization (2018-2029) & (MT)
• Figure 18. Global Biomaterials Production Market Share by Region in Percentage: 2022 Versus 2029
• Figure 19. Global Biomaterials Production Market Share by Region (2018-2029)
• Figure 20. Biomaterials Production Growth Rate in North America (2018-2029) & (MT)
• Figure 21. Biomaterials Production Growth Rate in Europe (2018-2029) & (MT)
• Figure 22. Biomaterials Production Growth Rate in China (2018-2029) & (MT)
• Figure 23. Biomaterials Production Growth Rate in Japan (2018-2029) & (MT)
• Figure 24. Global Biomaterials Revenue, (US$ Million), 2018 VS 2022 VS 2029
• Figure 25. Global Biomaterials Revenue 2018-2029 (US$ Million)
• Figure 26. Global Biomaterials Revenue (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
• Figure 27. Global Biomaterials Revenue Market Share by Region in Percentage: 2022 Versus 2029
• Figure 28. Global Biomaterials Revenue Market Share by Region (2018-2029)
• Figure 29. Global Biomaterials Sales 2018-2029 ((MT)
• Figure 30. Global Biomaterials Sales (CAGR) by Region: 2018 VS 2022 VS 2029 (MT)
• Figure 31. Global Biomaterials Sales Market Share by Region (2018-2029)
• Figure 32. US & Canada Biomaterials Sales YoY (2018-2029) & (MT)
• Figure 33. US & Canada Biomaterials Revenue YoY (2018-2029) & (US$ Million)
• Figure 34. Europe Biomaterials Sales YoY (2018-2029) & (MT)
• Figure 35. Europe Biomaterials Revenue YoY (2018-2029) & (US$ Million)
• Figure 36. China Biomaterials Sales YoY (2018-2029) & (MT)
• Figure 37. China Biomaterials Revenue YoY (2018-2029) & (US$ Million)
• Figure 38. Asia (excluding China) Biomaterials Sales YoY (2018-2029) & (MT)
• Figure 39. Asia (excluding China) Biomaterials Revenue YoY (2018-2029) & (US$ Million)
• Figure 40. Middle East, Africa and Latin America Biomaterials Sales YoY (2018-2029) & (MT)
• Figure 41. Middle East, Africa and Latin America Biomaterials Revenue YoY (2018-2029) & (US$ Million)
• Figure 42. The Biomaterials Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
• Figure 43. The Top 5 and 10 Largest Manufacturers of Biomaterials in the World: Market Share by Biomaterials Revenue in 2022
• Figure 44. Global Biomaterials Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
• Figure 45. Global Biomaterials Sales Market Share by Materials (2018-2029)
• Figure 46. Global Biomaterials Revenue Market Share by Materials (2018-2029)
• Figure 47. Global Biomaterials Sales Market Share by Application (2018-2029)
• Figure 48. Global Biomaterials Revenue Market Share by Application (2018-2029)
• Figure 49. US & Canada Biomaterials Sales Market Share by Materials (2018-2029)
• Figure 50. US & Canada Biomaterials Revenue Market Share by Materials (2018-2029)
• Figure 51. US & Canada Biomaterials Sales Market Share by Application (2018-2029)
• Figure 52. US & Canada Biomaterials Revenue Market Share by Application (2018-2029)
• Figure 53. US & Canada Biomaterials Revenue Share by Country (2018-2029)
• Figure 54. US & Canada Biomaterials Sales Share by Country (2018-2029)
• Figure 55. U.S. Biomaterials Revenue (2018-2029) & (US$ Million)
• Figure 56. Canada Biomaterials Revenue (2018-2029) & (US$ Million)
• Figure 57. Europe Biomaterials Sales Market Share by Materials (2018-2029)
• Figure 58. Europe Biomaterials Revenue Market Share by Materials (2018-2029)
• Figure 59. Europe Biomaterials Sales Market Share by Application (2018-2029)
• Figure 60. Europe Biomaterials Revenue Market Share by Application (2018-2029)
• Figure 61. Europe Biomaterials Revenue Share by Country (2018-2029)
• Figure 62. Europe Biomaterials Sales Share by Country (2018-2029)
• Figure 63. Germany Biomaterials Revenue (2018-2029) & (US$ Million)
• Figure 64. France Biomaterials Revenue (2018-2029) & (US$ Million)
• Figure 65. U.K. Biomaterials Revenue (2018-2029) & (US$ Million)
• Figure 66. Italy Biomaterials Revenue (2018-2029) & (US$ Million)
• Figure 67. Russia Biomaterials Revenue (2018-2029) & (US$ Million)
• Figure 68. China Biomaterials Sales Market Share by Materials (2018-2029)
• Figure 69. China Biomaterials Revenue Market Share by Materials (2018-2029)
• Figure 70. China Biomaterials Sales Market Share by Application (2018-2029)
• Figure 71. China Biomaterials Revenue Market Share by Application (2018-2029)
• Figure 72. Asia Biomaterials Sales Market Share by Materials (2018-2029)
• Figure 73. Asia Biomaterials Revenue Market Share by Materials (2018-2029)
• Figure 74. Asia Biomaterials Sales Market Share by Application (2018-2029)
• Figure 75. Asia Biomaterials Revenue Market Share by Application (2018-2029)
• Figure 76. Asia Biomaterials Revenue Share by Region (2018-2029)
• Figure 77. Asia Biomaterials Sales Share by Region (2018-2029)
• Figure 78. Japan Biomaterials Revenue (2018-2029) & (US$ Million)
• Figure 79. South Korea Biomaterials Revenue (2018-2029) & (US$ Million)
• Figure 80. China Taiwan Biomaterials Revenue (2018-2029) & (US$ Million)
• Figure 81. Southeast Asia Biomaterials Revenue (2018-2029) & (US$ Million)
• Figure 82. India Biomaterials Revenue (2018-2029) & (US$ Million)
• Figure 83. Middle East, Africa and Latin America Biomaterials Sales Market Share by Materials (2018-2029)
• Figure 84. Middle East, Africa and Latin America Biomaterials Revenue Market Share by Materials (2018-2029)
• Figure 85. Middle East, Africa and Latin America Biomaterials Sales Market Share by Application (2018-2029)
• Figure 86. Middle East, Africa and Latin America Biomaterials Revenue Market Share by Application (2018-2029)
• Figure 87. Middle East, Africa and Latin America Biomaterials Revenue Share by Country (2018-2029)
• Figure 88. Middle East, Africa and Latin America Biomaterials Sales Share by Country (2018-2029)
• Figure 89. Brazil Biomaterials Revenue (2018-2029) & (US$ Million)
• Figure 90. Mexico Biomaterials Revenue (2018-2029) & (US$ Million)
• Figure 91. Turkey Biomaterials Revenue (2018-2029) & (US$ Million)
• Figure 92. Israel Biomaterials Revenue (2018-2029) & (US$ Million)
• Figure 93. GCC Countries Biomaterials Revenue (2018-2029) & (US$ Million)
• Figure 94. Biomaterials Value Chain
• Figure 95. Biomaterials Production Process
• Figure 96. Channels of Distribution
• Figure 97. Distributors Profiles
• Figure 98. Bottom-up and Top-down Approaches for This Report
• Figure 99. Data Triangulation
• Figure 100. Key Executives Interviewed